about
Genetic and molecular analyses of PEG10 reveal new aspects of genomic organization, transcription and translationA machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastomaThe direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer.MYC in breast tumor progressionSézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.Immunotherapy with dendritic cells and cytokine-induced killer cells for MDA-MB-231 breast cancer stem cells in nude mice.PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancerTSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladderMolecular mechanisms of genomic imprinting and clinical implications for cancer.Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.Comparative proteomic analyses of two reovirus T3D subtypes and comparison to T1L identifies multiple novel proteins in key cellular pathogenic pathways.Long non-coding RNAs in B-cell malignancies: a comprehensive overview.Mammalian gene PEG10 expresses two reading frames by high efficiency -1 frameshifting in embryonic-associated tissues.TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cellsThe H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.A bioinformatics-to-clinic sequential approach to analysis of prostate cancer biomarkers using TCGA datasets and clinical samples: a new method for precision oncology?Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression
P2860
Q28749419-AD59F441-A250-46EB-BF01-32E84B66192CQ30274830-CAF1797E-2F85-419C-BBE8-5AD2ADD3CD9BQ33492610-D82EA750-A0CC-4283-9EF2-53981F313687Q34112882-E0A8043B-5215-4938-91D8-F389720A78C6Q34524915-59BA775F-C40F-49E2-9A82-5BC3F78989FAQ34717463-9CC68A50-AEAD-4A06-AAEF-03364B3A286CQ36186975-5F3BC5E0-BA85-459D-9385-BCDD75B5433AQ37144025-21EFD919-A697-4535-86EA-B43AB87DAF6FQ37640708-715181E1-A3F6-477F-9A12-FF73E71D14A7Q37652655-14B2DE2F-2F25-44CA-8F18-74941E172F31Q37831991-406844E8-0649-4F17-AADC-522CA6CB6355Q37988364-DB3AF45B-EB2D-4D9B-B77A-E4636BC18EADQ39961724-C4EDCB11-35C6-4B29-8ABF-310F3E52A214Q41299067-B70B804E-E9AD-4096-A11E-4DC3DF431F90Q41694305-6199DCE8-C31D-41B4-B014-A4A803D6ED02Q42634716-BE9F8162-6A21-49EC-8265-8198CE8C5A39Q42677448-26EF2D58-0471-426D-A9A4-FFE85799B4BCQ46207048-4C504293-E27E-4390-88DB-F80FE258179BQ47109041-BAF45366-7E05-4814-8058-609AA23A208EQ50178323-13270767-4CB7-4088-97DE-1661283DFE7EQ51145791-1BA724F1-2DAA-4F1E-92BD-2385968B85A0Q58786432-7EEE6236-E456-4333-9828-CAE6E4570F45
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
PEG10 is a c-MYC target gene in cancer cells
@ast
PEG10 is a c-MYC target gene in cancer cells
@en
PEG10 is a c-MYC target gene in cancer cells
@nl
type
label
PEG10 is a c-MYC target gene in cancer cells
@ast
PEG10 is a c-MYC target gene in cancer cells
@en
PEG10 is a c-MYC target gene in cancer cells
@nl
prefLabel
PEG10 is a c-MYC target gene in cancer cells
@ast
PEG10 is a c-MYC target gene in cancer cells
@en
PEG10 is a c-MYC target gene in cancer cells
@nl
P2093
P1433
P1476
PEG10 is a c-MYC target gene in cancer cells
@en
P2093
Adam A Margolin
Apostolos Klinakis
Benjamin Tycko
Chi-Ming Li
Hanina Hibshoosh
Lorenzo Memeo
Mahesh Mansukhani
Martha Salas
Matthias Szabolcs
P304
P356
10.1158/0008-5472.CAN-05-1553
P407
P577
2006-01-15T00:00:00Z